Supported by Cord Blood Banking Technology, Global Stem Cells Market is Expected to Reach US$63.8 Billion by 2015, with a CAGR of 24.2% During 2010-20

15 Jul 2010 • by Natalie Aster

The ‘Stem Cells Market and Technologies, 2009-2015’ reviews the latest trends in the stem cells market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science and healthcare sector investments. The study reveals profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

• Stem cell market trends in emerging markets
• Advancements in the technological space
• Demand of the market segments (by-region)
• Key growth areas and market size
• Competitors’ edge

The analysis primarily deals with major stem cells product segments and stem cells technologies, detailing region-wise growth rates. The stem cells product segments include adult stem cells, cord blood stem cells, embryonic stem cells and others. The major stem cells technologies discussed in the report are:

• Cell Based Technologies
• Cord Blood Banking
• Cryopreservation
• Stem Cell Banking
• Stem Cell Characterization
• Stem Cell Drug Discovery
• Stem Cell Production
• Stem Cell Transplants
• Xenotransplantation and
• Others (Blood Transfusion and Molecular Biology and Others)

The report centers on major current market trends, estimates and forecasts for the period 2009-2015. More than 500 leading market players are identified and 37 key companies that project improved market activities in the near future are profiled. The report consists of 321 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.

The region wise distribution of the market covers North America (USA, Canada and Mexico), Europe (Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom and Rest of Europe), Asia-Pacific (Australia, China, India, Japan, South Korea and Rest of Asia-Pacific), Latin America (Argentina and Brazil) and Rest of the World (Columbia, Middle East, South Africa and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.

New trends in stem cell technologies realized multidisciplinary research consortia among academic, medical, government and industry partners. Anticipating a boom in technological space, the consortia members are expected to be benefitted in the application front and in practicing stem-cell technology in life science arena.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the stem cells industry.

Global Market Watch:

Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. Our study on the stem cell technologies reveals that cord blood banking and xenotransplantation are expected to lead the technologies during 2010-2015. Drug discovery and stem cell transplantation techniques are also expected to ground in the upcoming years.

The stem cell market is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015, could fetch improved industry investments in the region in comparison with North America and Europe.

Improving health consciousness in Europe will likely maintain the Union competent with Asia-Pacific/North America. India possesses the potential to occupy the leading position in stem cell market growth with a CAGR exceeding 28 percent through 2015. Spain, Sweden and Germany are anticipated to top among the European countries with an annual compounded growth rate of more than 27 percent respectively through 2010-2015. Latin American countries will not likely experience a massive growth rate in comparison with North American/Asian economies. Overall, emerging economies could tag higher growth rate stem cells market in the next few years.

Some companies mentioned out of 500 companies:

AASTROM BIOSCIENCES, INC.
ACORDA THERAPEUTICS, INC.
ADVANCED CELL TECHNOLOGY, INC.
AFFYMETRIX, INC
ALPHA CORD, INC
ANGIOBLAST SYSTEMS, INC.
BIOHEART, INC
BOEHRINGER-INGELHEIM GMBH
CELL THERAPEUTICS, INC.
CELLS4LIFE LTD.
CORCELL, INC.
CORD BLOOD REGISTRY
CORDLIFE LTD.
CRYOCORD SDN. BHD.
And many more…………